SCHEMBL4830928

SCHEMBL4830928

CCc1ccc(S(=O)(=O)Nc2ccc(N3C=Nc4occc4C3N)cc2)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ UCHL1 P09936 1/20 0.46
▸ ALDH1A1 P00352 3/20 0.46
▸ KMT2A Q03164 2/20 0.45
▸ L3MBTL1 Q9Y468 1/20 0.45
▸ MAPT P10636 3/20 0.41
▸ TP53 P04637 1/20 0.40
▸ PTPN2 P17706 1/20 0.40
▸ PTPN1 P18031 1/20 0.40
▸ PTPN5 P54829 1/20 0.40
▸ GHSR Q92847 1/20 0.39
▸ FFAR4 Q5NUL3 1/20 0.39
▸ LMNA P02545 2/20 0.38
▸ KIT P10721 1/20 0.38
▸ MEN1 O00255 1/20 0.38
▸ HTT P42858 2/20 0.38
▸ NPSR1 Q6W5P4 1/20 0.38
▸ ADRB2 P07550 2/20 0.37
▸ ADRB1 P08588 2/20 0.37
▸ ADRB3 P13945 2/20 0.37
▸ SMN1; SMN2 Q16637 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4833351 0.92 FFAR4 (0.40) UCHL1ALDH1A1KMT2AL3MBTL1MAPT
SCHEMBL4833717 0.91 FFAR1 (0.48) MAPTTP53GHSRFFAR4LMNA
SCHEMBL4834410 0.87 CA1 (0.47) ALDH1A1KMT2AMAPTFFAR4LMNA
SCHEMBL4833953 0.87 PKM (0.44) ALDH1A1KMT2AMAPTLMNAMEN1
SCHEMBL4831477 0.86 ALDH1A1 (0.48) ALDH1A1KMT2AMAPTLMNAMEN1
SCHEMBL4833811 0.86 POLB (0.47) ALDH1A1KMT2AMAPTGHSRLMNA
SCHEMBL4834025 0.86 CA1 (0.50) ALDH1A1KMT2AMAPTGHSRFFAR4
SCHEMBL4834296 0.86 SMN1; SMN2 (0.47) ALDH1A1KMT2AMAPTTP53LMNA
SCHEMBL4833624 0.85 POLB (0.49) ALDH1A1KMT2AL3MBTL1MAPTTP53
SCHEMBL4831006 0.84 NPY5R (0.42) KMT2AMAPTPTPN2PTPN1PTPN5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080287466-A1 4-AMINO-2,3-DISUBSTITUTED THIENO [2,3,D]PYRIMIDINES AND PHARMACEUTICAL COMPOSITIONS THEREOF ADAMS JERRY LEROY 2008-11-20 — — US claimed
US-20050004142-A1 Chemical compounds SMITHKLINE BEECHAM CORPORATION 2005-01-06 — — US claimed
US-20080287466-A1 4-AMINO-2,3-DISUBSTITUTED THIENO [2,3,D]PYRIMIDINES AND PHARMACEUTICAL COMPOSITIONS THEREOF ADAMS JERRY LEROY 2008-11-20 — — US disclosed
US-7427623-B2 4-Amino-2,3-disubstituted thieno[2,3-d]pyrimidines and pharmacetical compositions thereof SMITHKLINE BEECHAM CORPORATION (US) 2008-09-23 — — US disclosed
US-20050004142-A1 Chemical compounds SMITHKLINE BEECHAM CORPORATION 2005-01-06 — — US disclosed
EP-1425284-A2 FURO- AND THIENOPYRIMIDINE DERIVATIVES AS ANGIOGENESIS INHIBITORS SMITHKLINE BEECHAM CORPORATION (US) 2004-06-09 — — EP disclosed
WO-2003022852-A2 FURO-AND THIENOPYRIMIDINE DERIVATIVES AS ANGIOGENESIS INHIBITORS SMITHKLINE BEECHAM CORPORATION (US) 2003-03-20 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050004142-A1 Chemical compounds TIE1, KDR, TEK UCHL1 4481/4885ALDH1A1 906/4885KMT2A 324/4885
US-20080287466-A1 4-AMINO-2,3-DISUBSTITUTED THIENO [2,3,D]PYRIMIDINES AND PHARMACEUTICAL COMPOSITIONS THEREOF TIE1, TEK, KDR UCHL1 4674/4885ALDH1A1 1144/4885KMT2A 334/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback